Adenovirus type 4 a
Ended Awarded Last action
- Contract number
- SPE2DP26F5465
- Awardee
-
Teva Pharmaceuticals Usa, Inc. UEI NEN9A34LRHJ5
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $171,763
Award facts
- Contract value 100% obligated
- $171,763.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Parsippany, NJ 07054, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Defense Medical Supply Chain issued a $171,763.20 delivery order to Teva Pharmaceuticals Usa, Inc. on May 11, 2026, for Adenovirus Type 4 vaccine, with completion scheduled for May 19, 2026.
The order is firm fixed price with no set-aside. Place of performance is Parsippany, New Jersey. The delivery order calls against Teva's primary Indefinite Delivery Contract (SPE2DP20D0002) with Defense Logistics Agency Troop Support Medical, which carries a combined potential value of $665.9 million across 559 delivery orders and supports critical military immunization programs.
Quick answers
Who was awarded contract SPE2DP26F5465?
SPE2DP26F5465 was awarded to Teva Pharmaceuticals Usa, Inc. by Medical Supply Chain (Troop Support) on May 11, 2026.
How much is contract SPE2DP26F5465 worth?
The government has obligated $171,763 on SPE2DP26F5465.
Is contract SPE2DP26F5465 an order under another contract?
Yes. SPE2DP26F5465 is a delivery order under SPE2DP20D0002, an indefinite delivery contract.
Was contract SPE2DP26F5465 competed?
The extent of competition for SPE2DP26F5465 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award